Abstract
It may be therapeutically advantageous to alter tumour blood supply specifically. Nitric oxide is a potent vasodilator which is produced in many tissues by the enzyme nitric oxide synthase (NOS). We have transfected cDNA for the inducible isoform of this enzyme (iNOS), under the control of the radiation-inducible promoter WAF1. The activity of the promoter was initially assessed using green fluorescent protein (GFP) in both endothelial cells and rat tail artery segments. Induction of protein expression by 9.5- and 4.5-fold respectively, was observed after a radiation dose of 4 Gy. Artery sections were then transfected with the WAF1/iNOS construct; this gave five-fold induction of iNOS protein after a dose of 4 Gy. The transfected artery was also tested functionally for relaxation, indicative of NO production. One hour after exposure to 4 Gy there was a significant (65%) relaxation of artery segments that had been preconstricted with phenylephrine. This could be partially reversed by the NOS inhibitor nitro-L-arginine. This study demonstrates that we can regulate vascular tone using an X-ray inducible promoter.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kullo IJ, Simaro RD, Schartz RS . Vascular gene transfer from bench to bedside Arterioscler Thromb Vasc Biol 1999 19: 196–207
Nabel EG et al. Recombinant fibroblast growth-factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo Nature 1993 362: 844–846
Ohno T et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury Science 1994 265: 781–784
Palu G et al. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans Gene Therapy 1999 6: 330–337
Stewart AK et al. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial Gene Therapy 1999 6: 350–363
Denekamp J . Vascular attack as a therapeutic strategy for cancer Cancer Metast Rev 1990 9: 267–282
Geller DA, Billiar TR . Molecular biology of nitric oxide synthases Cancer Metast Rev 1998 17: 7–23
Sherman PA et al. Purification and cDNA sequence of an iNOS from a tumour cell line Biochemistry 1993 32: 11600–11605
Thomsen LL et al. NOS activity in human gynecological cancer Cancer Res 1994 54: 1352–1354
Fujisawa H et al. Inducible nitric oxide synthase in a human glioblastoma cell line J Neurochem 1995 64: 85–91
Kasahara N, Dozy A, Kan Y . Tissue-specific targeting of retroviral vectors through ligand–receptor interactions Science 1994 266: 1373–1376
Manome Y et al. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene Cancer Res 1994 54: 5408–5413
Gossen M, Bujard H . Tight control of gene expression in transgenic mice by tetracycline-responsive promoters Proc Natl Acad Sci USA 1992 89: 5547–5551
Wang Y et al. A regulatory system for use in gene transfer Proc Natl Acad Sci USA 1994 91: 8180–8184
Burcin MM et al. Adenovirus-mediated regulable target gene expression in vivo Proc Natl Acad Sci USA 1999 2: 355–360
Weichselbaum RR et al. Gene therapy targeted by radiation preferentially radiosensitizes tumour cells Cancer Res 1994 54: 4266–4269
Hallahan DE et al. Spatial and temporal control of gene therapy using ionising radiation Nature Med 1995 8: 786–791
Manome Y et al. Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the EGR-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine Hum Gene Ther 1998 9: 1409–1417
Keyse SM . The induction of gene expression in mammalian cells by radiation Semin Cancer Biol 1993 4: 119–128
El -Deiry SW et al. WAF1, a potential mediator of p53 tumour suppression Cell 1993 75: 817–825
Ho YS, Wang YJ, Lin JK . Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells Mol Carcinog 1996 16: 20–31
Miller N, Whelan J . Progress in transcriptionally targeted and regulable vectors for genetic therapy Hum Gene Ther 1997 8: 803–815
Goud C et al. Cyclic GMP-independent mechanisms of nitric oxide induced vasodilation Gen Pharmacol 1999 1: 51–55
Tzeng E et al. Expression of human inducible NO synthase in a tetrahydrobiopterin-deficient cell line: tetrahydrobiopterin promotes assembly of enzyme subunits into an active dimer Proc Natl Acad Sci USA 1995 92: 11771–11775
Lancaster Jr JR . Simulation of the diffusion and reaction of endogenously produced nitric oxide Proc Natl Acad Sci USA 1994 91: 8137–8141
Tzeng E et al. Vascular gene transfer of the human iNOS: characterisation of activity and effects on myointimal hyperplasia Mol Med 1996 2: 211–225
McKeown SR et al. AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo Br J Cancer 1995 72: 76–81
Morishita K, Johnson DE, Williams LT . A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression J Biol Chem 1995 270: 27948–27953
Andes EW et al. HMEC-1 – establishment of an immortalised human microvascular endothelial cell line J Invest Dermatol 1992 99: 683–690
Hirst DG et al. Upstream modification of vasoconstrictor responses in rat epigastric artery supplying an implanted tumour Adv Exp Mod Biol 1994 345: 411–416
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Worthington, J., Robson, T., Murray, M. et al. Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Ther 7, 1126–1131 (2000). https://doi.org/10.1038/sj.gt.3301224
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301224
Keywords
This article is cited by
-
Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model
Molecular Cancer (2013)
-
Regulation of gene expression in prostate cancer cells with an artificially constructed promoter responsive to radiation
Gene Therapy (2012)
-
The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation
Gene Therapy (2008)
-
p21(WAF1)-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy
Gene Therapy (2007)
-
Plasmid Engineering for Controlled and Sustained Gene Expression for Nonviral Gene Therapy
Pharmaceutical Research (2006)